Trial Profile
Safety and efficacy of sofosbuvir in combination with simeprevir in Egyptian patients with hepatitis C virus infection
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 16 May 2016
Price :
$35
*
At a glance
- Drugs Simeprevir (Primary) ; Sofosbuvir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 16 May 2016 New trial record
- 17 Apr 2016 Results presented at The International Liver Congress™ 2016